Arrowhead Pharmaceuticals logo
Arrowhead Pharmaceuticals ARWR
$ 19.23 -2.44%

Quarterly report 2024-Q2
added 08-08-2024

report update icon

Arrowhead Pharmaceuticals Balance Sheet 2011-2024 | ARWR

Annual Balance Sheet Arrowhead Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Net Debt

4.28 M -26.4 M -159 M - -222 M -27.8 M -22.3 M -82.6 M -80.5 M -131 M -18.1 M -1.04 M -6.9 M

Long Term Debt

105 M 78.8 M 23.3 M - - 2.1 M 2.33 M 2.53 M - - 50 K 839 K 607 K

Long Term Debt Current

10.6 M 2.78 M 2.25 M 1.09 M - - - - - - - - -

Total Non Current Liabilities

373 M 135 M 155 M 20 M 8.74 M 4 M 4.45 M 7.51 M 6.75 M 4.98 M 2.87 M 2.39 M 742 K

Total Current Liabilities

105 M 139 M 147 M 40.7 M 97.1 M 12.4 M 18.7 M 25.6 M 15.9 M 11.8 M 8.73 M 5.33 M 2.58 M

Total Liabilities

- - - - 106 M 16.4 M 23.2 M 33.2 M 22.6 M 16.8 M 11.6 M 7.72 M 3.32 M

Deferred Revenue

866 K 74.1 M 111 M 19.3 M 77.8 M 600 5.27 M 2.57 M 103 K 103 K 103 K 37.5 K -

Retained Earnings

-1.03 B -821 M -645 M -504 M -419 M -487 M -433 M -398 M -317 M -225 M -166 M -135 M -114 M

Total Assets

766 M 692 M 710 M 523 M 350 M 112 M 104 M 128 M 132 M 183 M 37.3 M 16.5 M 15.9 M

Cash and Cash Equivalents

111 M 108 M 184 M 144 M 222 M 30.1 M 24.8 M 85.4 M 81.2 M 133 M 19.1 M 3.38 M 7.51 M

Book Value

766 M 692 M 710 M 523 M 244 M 95.2 M 80.9 M 95 M 110 M 166 M 25.7 M 8.81 M 12.6 M

Total Shareholders Equity

271 M 399 M 409 M 462 M 245 M 95.8 M 81.4 M 95.6 M 110 M 167 M 27.5 M 10 M 12.8 M

All numbers in USD currency

Quarterly Balance Sheet Arrowhead Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Long Term Debt

112 M 114 M 115 M 105 M 79.9 M 80.1 M 79.5 M 78.8 M - 22.7 M 22.5 M 23.3 M 22.9 M 23.3 M 19.7 M 20 M 20 M 20 M 14.4 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Total Non Current Liabilities

448 M 395 M 389 M 373 M 344 M 339 M 373 M 135 M - 112 M 129 M 155 M 103 M 155 M 19.7 M 20 M 20 M 20 M 14.4 M 8.74 M 8.74 M 8.74 M 34.8 M 4 M 4 M 4 M 4.3 M 4.45 M 4.45 M 4.45 M 10.1 M 7.51 M 7.51 M 7.51 M 6.68 M 6.75 M 6.75 M 6.75 M 4.93 M 4.98 M 4.98 M 4.98 M 2.76 M 2.87 M 2.87 M 2.87 M 1.55 M 2.39 M 2.39 M 2.39 M 2.25 M 742 K 742 K 742 K

Total Liabilities

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Deferred Revenue

- - - 866 K 16.9 M 29.8 M 66.3 M 74.1 M - 97.9 M 109 M 111 M 151 M 111 M 6.74 M 19.3 M 19.3 M 19.3 M 54 M 77.8 M 77.8 M 77.8 M 125 M 600 943 K 1.56 M 1.88 M 5.27 M 5.27 M 5.27 M 25.6 M 2.57 M 2.57 M 2.57 M 109 K 103 K 103 K 103 K 109 K 103 K 103 K 103 K 109 K 103 K 103 K 103 K 109 K 37.5 K 37.5 K 37.5 K 101 K - - -

Retained Earnings

-1.45 B -1.28 B -1.16 B -1.03 B -916 M -813 M -862 M -821 M - -663 M -708 M -645 M -581 M -645 M -525 M -504 M -504 M -504 M -422 M -419 M -419 M -419 M -475 M -487 M -487 M -487 M -446 M -433 M -433 M -433 M -411 M -398 M -398 M -398 M -336 M -317 M -317 M -317 M -247 M -225 M -225 M -225 M -177 M -166 M -166 M -166 M -140 M -135 M -135 M -135 M -116 M -114 M -114 M -114 M

Total Assets

884 M 955 M 626 M 766 M 796 M 891 M 891 M 692 M - 704 M 639 M 710 M 735 M 710 M 499 M 523 M 523 M 523 M 588 M 350 M 350 M 350 M 341 M 112 M 112 M 112 M 88.2 M 104 M 104 M 104 M 144 M 128 M 128 M 128 M 111 M 132 M 132 M 132 M 162 M 183 M 183 M 183 M 92.7 M 37.3 M 37.3 M 37.3 M 15.2 M 16.5 M 16.5 M 16.5 M 23.1 M 15.9 M 15.9 M 15.9 M

Cash and Cash Equivalents

69.4 M 128 M 58.2 M 111 M 105 M 135 M 202 M 108 M - 86.4 M 91.6 M 184 M 326 M 184 M 140 M 144 M 144 M 144 M 461 M 222 M 222 M 222 M 190 M 30.1 M 30.1 M 30.1 M 11.5 M 24.8 M 24.8 M 11.5 M 102 M 85.4 M 85.4 M 102 M 62.2 M 81.2 M 81.2 M 62.2 M 104 M 133 M 133 M 104 M 59.7 M 19.1 M 19.1 M 59.7 M 2.93 M 3.38 M 3.38 M 2.93 M 6.77 M 7.51 M 7.51 M 6.77 M

Book Value

884 M 955 M 626 M 766 M 796 M 891 M 891 M 692 M - 704 M 639 M 710 M 735 M 710 M 499 M 523 M 523 M 523 M 588 M 350 M 350 M 350 M 341 M 112 M 112 M 112 M 88.2 M 104 M 104 M 104 M 144 M 128 M 128 M 128 M 111 M 132 M 132 M 132 M 162 M 183 M 183 M 183 M 92.7 M 37.3 M 37.3 M 37.3 M 15.2 M 16.5 M 16.5 M 16.5 M 23.1 M 15.9 M 15.9 M 15.9 M

Total Shareholders Equity

331 M 484 M 160 M 271 M 382 M 465 M 396 M 399 M 474 M 452 M 373 M 409 M 437 M 373 M 454 M 462 M 493 M 494 M 500 M 245 M 245 M 245 M 172 M 95.8 M 95.8 M 95.8 M 70.8 M 81.4 M 81.4 M 81.4 M 97.8 M 95.6 M 95.6 M 95.6 M 92.9 M 110 M 110 M 110 M 146 M 167 M 167 M 167 M 82.7 M 27.5 M 27.5 M 27.5 M 8.97 M 10 M 10 M 10 M 16.2 M 12.8 M 12.8 M 12.8 M

All numbers in USD currency